RCT: Effects of prophylactic oral dextrose gel on neurosensory impairment at 2-year follow-up in late preterm and term infants born at risk of neonatal hypoglycemia.

Prophylactic Oral Dextrose Gel and Neurosensory Impairment at 2-Year Follow-up of Participants in the hPOD Randomized Trial – JAMA (link to abstract – $ for full-text)

Commentary: New insight into protecting newborns with low blood sugars – University of Auckland

Related:

Cohort Study: No association of neonatal hypoglycemia with academic performance in mid-childhood.

Oral dextrose gel for the treatment of hypoglycemia in newborn infants.

Commentary on Twitter

@EdwardsTaygen et al present 2-year Neurosensory Follow-Up results from their multicenter, double-blinded, placebo controlled hPOD randomized trial @JAMA_current https://t.co/ik6AKIjahS #EBNEOalerts, #neotwitter, #neoEBM pic.twitter.com/dQH8qti5Fv

— Evidence-Based Neo (@EBNEO) March 25, 2022